Our Science
UM
National Institutes of Health
NIH/NINDS HEAL UH3 Award
Award to Support All Formal CMC and Pre-Clinical GLP/GMP/GCP Development Work Through a First-in-Human Study in Patients with Moderate to Severe Chronic Knee Pain Due to Osteoarthritis Pain.
University of Miami
Exclusive License Agreement for Patents Protecting Non-Enzymatic Carbonic Anhydrase DNA Constructs, Their Protein Products, Gene Therapies and Uses Managing Pain.
University of Pittsburgh
Exclusive License Agreement for Patents Protecting Non-Toxic Replication-Defective HSV Vectors for Efficient Gene Delivery Applications and Complementing Cells for Their Production.
National Institutes of Health
NIH/NINDS HEAL UH3 Award
Award to Support All Formal CMC and Pre-Clinical GLP/GMP/GCP Development Work Through a First-in-Human Study in Patients with Moderate to Severe Chronic Knee Pain Due to Osteoarthritis Pain.
University of Miami
Exclusive License Agreement for Patents Protecting Non-Enzymatic Carbonic Anhydrase DNA Constructs, Their Protein Products, Gene Therapies and Uses Managing Pain.
University of Pittsburg
Exclusive License Agreement for Patents Protecting Non-Toxic Replication-Defective HSV Vectors for Efficient Gene Delivery Applications and Complementing Cells for Their Production.
Market Exclusivity Drivers
*Typical Patent Expiry upon grant is 20 years from priority date, excluding any patent term extensions or other term adjustments